Lower respiratory tract infections (LRTIs) remain the most common illnesses in children, accounting for up to two-thirds of pediatric outpatient and ...

Axuall, the industry leader in clinical workforce intelligence, and the world-renowned Cleveland Clinic today announced a ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in ...

Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on terlipressin in patients with hepatorenal syndrome-acute kidney injury (HRS-AKI), at ...

RLF-OD032 demonstrated bioequivalence to KUVAN® PowderStudy results support planned 505(b)(2) NDA submission in early 2026 GENEVA, SWITZERLAND / ACCESS Newswire / October 29, 2025 / RELIEF ...

Q3 2025 Earnings Call October 30, 2025 8:30 AM EDTCompany ParticipantsJon Cohen - CEO & DirectorIan Harris - Chief ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that it will be presenting new data highlighting insights on patient outcomes with rozanolixizumab and zilucoplan for ...

Smith+Nephew announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure ...

A survey of reasoning behaviour in medical large language models uncovers emerging trends, highlights open challenges, and introduces theoretical frameworks that enhance reasoning behaviour ...

Science must guide treatment decisions, and healthcare practitioners must take decisive action now to stop inappropriate fibrate prescribing for cardiovascular risk reduction, especially on top of ...

VANCOUVER, BC / ACCESS Newswire / October 23, 2025 / North Shore Uranium Ltd. (TSXV:NSU) (“North Shore” or the “Company“) is ...